Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2008
11/27/2008US20080292616 Topical Formulations of Histone Deacetylase Inhibitors and Methods Using the Same
11/27/2008US20080292615 Diagnosis and treatment of disease
11/27/2008US20080292614 DNA sequences for human angiogenesis genes
11/27/2008US20080292546 Compositions and methods for treating and diagnosing cancer
11/27/2008US20080292545 Functionalized Encoded Apoferritin Nanoparticles and Processes for Making and Using Same
11/27/2008US20080292544 Modified Proteins, Designer Toxins, and Methods of Making Thereof
11/27/2008DE10251709B4 Screening-Verfahren für Wirkstoffe zur Stimulierung der humanen beta-Defensine vom Typ 2 und/oder Typ 3 Screening method for agents to stimulate the human beta-defensins type 2 and / or type 3
11/27/2008CA2688829A1 Novel rabbit antibody humanization methods and humanized rabbit antibodies
11/27/2008CA2688724A1 Novel simian t-cell lymphotropic virus
11/27/2008CA2688536A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cancer
11/27/2008CA2688146A1 Antibodies to il-6 and use thereof
11/27/2008CA2688009A1 Detoxified pneumococcal neuraminidase and uses thereof
11/27/2008CA2687791A1 Neutralizing antibodies
11/27/2008CA2687633A1 Amino acid sequences directed against growth factor receptors and polypeptides comprising the same for the treatment of diseases and disorders associated with growth factors and their receptors
11/27/2008CA2687632A1 Lyophilised antigen composition
11/27/2008CA2687493A1 Recombinant protein production in avian ebx r cells
11/27/2008CA2687441A1 Class a oligonucleotides with immunostimulatory potency
11/27/2008CA2687247A1 Inhibition of tumor metastasis by anti neuropilin 2 antibodies
11/27/2008CA2687117A1 Single-chain fc (scfc) regions, binding polypeptides comprising same, and methods related thereto
11/27/2008CA2686720A1 Drug delivery system with scleral lens
11/27/2008CA2686686A1 Il-9 in fibrotic and inflammatory disease
11/27/2008CA2686683A1 Il-33 in inflammatory disease
11/27/2008CA2685907A1 Method for diagnosis and treatment of pancreatic cancer
11/27/2008CA2685222A1 Methods of reducing eosinophil levels
11/27/2008CA2685049A1 Antibodies useful for therapy and diagnosis of cancer
11/27/2008CA2684134A1 Method and apparatus for the delivery of polynucleotide vaccines to mammalian skin
11/27/2008CA2683452A1 Use of an anti-cxcr4 antibody for treating cancer
11/27/2008CA2673477A1 Multivalent pneumococcal polysaccharide-protein conjugate composition
11/26/2008EP1995314A1 Method for production of erythro- or threo-2-amino-3-hydroxypropionic acid ester, novel carbonyl reductase, gene for the reductase, vector, transformant, and method for production of optically active alcohol using those
11/26/2008EP1995309A1 Recombinant protein production in avian EBx® cells
11/26/2008EP1995255A1 Truncated tau proteins
11/26/2008EP1994943A2 Chimeric vaccine antigens against classical swine fever virus
11/26/2008EP1994941A2 Medicine containing at least one oxidised protein
11/26/2008EP1994937A2 Prevention and treatment of amyloidogenic disease
11/26/2008EP1994181A2 Identification and use of novopeptides for the treatment of cancer
11/26/2008EP1994159A1 Use of recombinant modified vaccinia virus ankara (mva) for the treatment of type 1 hypersensitivity in a living animal including humans
11/26/2008EP1994155A1 Polynucleotides and polypeptide sequences involved in the process of bone remodeling
11/26/2008EP1994146A1 Cancerous disease modifying antibody 141205-02
11/26/2008EP1994145A2 Production of biologically active proteins
11/26/2008EP1994139A1 Live attenuated bordetella strains as a single dose vaccine against whooping cough
11/26/2008EP1994052A1 Use of iex-1 for the treatment of glioma tumors
11/26/2008EP1993673A2 Injectable combination therapy for eye disorders
11/26/2008EP1993606A2 Immunoglobulins from vitiligo plasma for melanoma therapy
11/26/2008EP1993605A1 Dry powder compositions and systems for poultry vaccination
11/26/2008EP1993604A2 Methods for preparing complex multivalent immunogenic conjugates
11/26/2008EP1993603A1 Hepatitis c virus non structural fusion protein
11/26/2008EP1993602A2 Adhesin-enterotoxin chimera based immunogenic composition against entertoxigenic escherichia coli
11/26/2008EP1993601A2 Non-coiled protective regions of pneumococcal surface proteins pspa and pspc
11/26/2008EP1993598A2 Methods of manufacturing corticosteroid solutions
11/26/2008EP1993597A2 Human telomerase reverse transcriptase peptides
11/26/2008EP1993596A1 Cancer vaccine
11/26/2008EP1993595A1 Tumour vaccine comprising allogeneic or xenogeneic tumour cells
11/26/2008EP1800134B1 Method for diagnosing and treating crohn's disease
11/26/2008EP1434592B1 Nucleic acid and corresponding protein entitled 121p2a3 useful in treatment and detection of cancer
11/26/2008EP1276492B1 P43 antigen for the immunodiagnosis of canine ehrlichiosis and uses thereof
11/26/2008EP1257642B1 Partners of ptb1 domain of fe65, preparation and uses
11/26/2008EP1234574B1 Hair growth stimulant
11/26/2008EP1173481B1 Inactivated cytokines for immunisation
11/26/2008EP1124953B1 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances
11/26/2008EP0865293B1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling
11/26/2008EP0821732B1 Altered polypeptides with increased half-life
11/26/2008EP0735893B1 Pan dr-binding peptides for enhancement of the immune response
11/26/2008CN101313221A Comprehensive diagnostic testing procedures for personalized anticancer chemotherapy(pac)
11/26/2008CN101313219A A method of diagnosis and treatment and agents useful for same
11/26/2008CN101313068A Streptococcus suis polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications
11/26/2008CN101313062A Cell populations having immunoregulatory activity, method for isolation and uses
11/26/2008CN101312989A Monoclonal antibodies against claudin-18 for treatment of cancer
11/26/2008CN101312744A Immunoglobulin fusion protein formulations
11/26/2008CN101312743A (s)-6-methyloxaalkyl exemestane compounds and related methods of use
11/26/2008CN101312742A Stabilizers for freeze-dried vaccines
11/26/2008CN101312741A Chemo-immunotherapy method
11/26/2008CN101311191A Method for preparing immune globulin against lymphocyte of human
11/26/2008CN101311190A Antigen epitope for exciting protective immunity against tubercle bacillus of human body and uses thereof
11/26/2008CN101311189A Antigen epitope for exciting protective immunity against tubercle bacillus of human body and uses thereof
11/26/2008CN101310770A Antibodies against cancer
11/26/2008CN101310769A Multivalent DTP-POLIO vaccines
11/26/2008CN100436471C Polynucleotide for identifying polypeptide OT3 and coding OT3 of tumor cell and uses thereof
11/26/2008CN100435846C Synthetic peptide vaccines for foot-and-mouth disease
11/26/2008CN100435845C Live attenuated vaccine against porcine pleuropneumonia
11/26/2008CN100435844C Use of escherichia coli heat labile toxin as an adjuvant in birds and poultry
11/26/2008CN100435784C Method for preparing inorganic salt nanometer particles containing and packing traditional Chinese medicine and its application
11/25/2008US7456264 Human monoclonal antibodies against Bacillus anthracis protective antigen
11/25/2008US7456262 Methods and composition for modulating and detecting wisp activity
11/25/2008US7456259 Cancerous disease modifying antibodies
11/25/2008US7456258 Isolated monoclonal antibody produced by hybridoma deposit IDAC accession number 170505-03; binding bioassays; customization of therapy designed for each individual; anticarcinogenic-, -tumor and -metastasis agents
11/25/2008US7456255 Nogo receptor homologs that decrease inhibition of axonal elongation
11/25/2008US7456153 Comprise at least a tryptophan-containing cell adhesion recognition sequence; cancer modulating agent
11/25/2008US7456018 Human hepatoma lines, methods for obtaining same and uses thereof
11/25/2008US7456011 For delivering a therapeutic protein to the mucosal surface of human vagina or gastrointestinal tract; binds to gp 120 of human immunodeficiency virus (HIV) and inhibits the infectivity of HIV
11/25/2008US7456009 Adenovirus formulations
11/25/2008US7455994 Methods for producing Marburg virus proteins
11/25/2008US7455991 Serpentine transmembrane antigens expressed in human cancers and uses thereof
11/25/2008US7455972 Determining presence, absence or quantity of murine Norovirus-1 (MNV-1) in a murine tissue, organ or feces sample by synthesizing complementary DNA from the sample RNA and detecting MNV-1 cDNA if present by a Polymerase chain reaction if MNV-1
11/25/2008US7455846 Immune potentiating compositions of cancer cells
11/25/2008US7455845 Use of neurotoxin therapy for treatment of urologic and related disorders related to lowering elevated bladder pressure
11/25/2008US7455844 Reduces the severity of strangles in an equine caused by Streptococcus equi infection; diagnostic kits
11/25/2008US7455843 useful for enhancing immune response to antigens; vaccines; applicable to mucosal immunization in humans
11/25/2008US7455842 Chimeric West Nile viruses and uses thereof
11/25/2008US7455841 Constitutive transport enhancer (CTE); Rev Responsive element (RRE); coding sequence for HIV-1 Rev, and a coding sequence for a desired protein that comprises a coding sequence for an HIV structural protein that includes an RRE and at least one CTE; genetic vaccines, gene therapy
11/25/2008US7455840 Inhibition of drug resistance to quinolone antibiotics by administering to the bacteria a quinolone and an agent that inhibits LexA, thereby inhibiting an SOS response pathway in the bacteria e.g. dipeptide Ala-Ala, alanylalanine or the gene/proteins PsiB, DinI
1 ... 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 ... 1823